Koob George F
Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA, USA.
Handb Clin Neurol. 2014;125:33-54. doi: 10.1016/B978-0-444-62619-6.00003-3.
Alcoholism, more generically drug addiction, can be defined as a chronically relapsing disorder characterized by: (1) compulsion to seek and take the drug (alcohol); (2) loss of control in limiting (alcohol) intake; and (3) emergence of a negative emotional state (e.g., dysphoria, anxiety, irritability), reflecting a motivational withdrawal syndrome, when access to the drug (alcohol) is prevented (defined here as dependence). The compulsive drug seeking associated with alcoholism can be derived from multiple neuroadaptations, but the thesis argued here, derived largely from animal models, is that a key component involves decreased brain reward function, increased brain stress function, and compromised executive function, all of which contribute to the construct of negative reinforcement. Negative reinforcement is defined as drug taking that alleviates a negative emotional state. The negative emotional state that drives such negative reinforcement is hypothesized to derive from decreases in reward neurotransmission in the ventral striatum, such as decreased dopamine and opioid peptide function in the nucleus accumbens (ventral striatum), but also recruitment of brain stress systems, such as corticotropin-releasing factor (CRF), in the extended amygdala. Data from animal models that support this thesis show that acute withdrawal from chronic alcohol, sufficient to produce dependence, increases reward thresholds, increases anxiety-like responses, decreases dopamine system function, and increases extracellular levels of CRF in the central nucleus of the amygdala. CRF receptor antagonists also block excessive drug intake produced by dependence. Alcoholism also involves substantial neuroadaptations that persist beyond acute withdrawal and trigger relapse and deficits in cognitive function that can also fuel compulsive drinking. A brain stress response system is hypothesized to be activated by acute excessive drug intake, to be sensitized during repeated withdrawal, to persist into protracted abstinence, and to contribute to the compulsivity of alcoholism. Other components of brain stress systems in the extended amygdala that interact with CRF and may contribute to the negative motivational state of withdrawal include increases in norepinephrine function, increases in dynorphin activity, and decreases in neuropeptide Y. The combination of impairment of function in reward circuitry and recruitment of brain stress system circuitry provides a powerful neurochemical basis for the negative emotional states that are responsible for the negative reinforcement that drives the compulsivity of alcoholism.
酒精成瘾,更广义地说是药物成瘾,可被定义为一种慢性复发性疾病,其特征为:(1)强迫性地寻求和服用药物(酒精);(2)在限制(酒精)摄入量方面失去控制;以及(3)当无法获取药物(酒精)时出现负面情绪状态(如烦躁不安、焦虑、易怒),这反映了一种动机性戒断综合征(在此定义为成瘾)。与酒精成瘾相关的强迫性药物寻求可源于多种神经适应性变化,但本文所主张的观点主要源自动物模型,即一个关键因素涉及大脑奖赏功能降低、大脑应激功能增强以及执行功能受损,所有这些都促成了负性强化机制的形成。负性强化被定义为通过服用药物来缓解负面情绪状态。据推测,驱使这种负性强化的负面情绪状态源自腹侧纹状体奖赏神经传递的减少,如伏隔核(腹侧纹状体)中多巴胺和阿片肽功能的降低,同时也源自大脑应激系统的激活,如在扩展杏仁核中促肾上腺皮质激素释放因子(CRF)的募集。来自动物模型的数据支持了这一观点,这些数据表明,从慢性酒精中急性戒断(足以导致成瘾)会提高奖赏阈值、增加类似焦虑的反应、降低多巴胺系统功能,并增加杏仁核中央核中CRF的细胞外水平。CRF受体拮抗剂也能阻断成瘾导致的过度药物摄入。酒精成瘾还涉及大量持续超过急性戒断期的神经适应性变化,这些变化会引发复发以及认知功能缺陷,而认知功能缺陷也可能助长强迫性饮酒行为。据推测,大脑应激反应系统会被急性过量药物摄入激活,在反复戒断过程中变得敏感,持续到长期戒酒阶段,并导致酒精成瘾的强迫性。扩展杏仁核中与CRF相互作用且可能导致戒断负性动机状态的大脑应激系统的其他组成部分包括去甲肾上腺素功能增强、强啡肽活性增加以及神经肽Y减少。奖赏回路功能受损与大脑应激系统回路激活相结合,为导致负性强化从而驱使酒精成瘾强迫性的负面情绪状态提供了强大的神经化学基础。